Business
SEC Investigating Genentech Trading: Genentech Inc. said the SEC is investigating trading in its stock ahead of its previously announced $500-million partial merger with Roche Holdings Inc.
May 4, 1990
Raptiva is the second biotech treatment for the skin condition, a category analysts see as a $1-billion market.
Oct. 28, 2003
Biotechnology giant Genentech Inc. on Friday forecast strong sales and earnings growth through 2005, signaling it expects to win government approval this year for new drugs to treat psoriasis and asthma.
March 15, 2003
Genentech Inc.’
May 24, 2005
Technology and the Internet
Genentech Shareholders File Suit: Four Genentech Inc. shareholders have filed suit in Delaware Chancery Court to block the sale of a 60% stake in the firm to Roche Holding Co., according to Federal Filings Inc.
Feb. 9, 1990
Genentech Inc. suffered a rare setback Wednesday when the biotech giant said its experimental cancer drug Tarceva failed to improve survival in lung cancer patients when given as a first treatment along with chemotherapy.
Oct. 2, 2003
Swiss drug maker Roche Holding said Tuesday that it acquired rights to sell Genentech Inc.’
July 9, 2003
Genentech Inc. reported a 43% drop in third-quarter profit and credited the decline to its continued investment in research and development.
Oct. 16, 1992
Pharmaceuticals: Pact gives biotech firm new early-stage respiratory product candidates.
Dec. 22, 1999
A judge has ruled that MedImmune Inc. cannot pursue antitrust claims in its suit to invalidate a patent controlled by Genentech Inc. for the method to create drugs using antibody molecules to fight diseases.
Dec. 27, 2003